Roche Venture Fund — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Co-investorsAvego BioScience CapitalBioGenerator VenturesPerot JainRiverVest Venture PartnersSR One Capital Management
Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.
BiotechHealthtechAustin, US
Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in
Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante Health VenturesSante VenturesWellcome Trust
Co-investorsLifeforce CapitalPfizer Venture InvestmentsDigitalis VenturesLightstone VenturesMorgenthalerSR One Capital Management
Soteria provides cybersecurity advisory services and solutions, including managed detection and response (MDR), virtual CISO support, domain monitoring, and Microsoft 365 risk management.
CybersecurityEnterprise SoftwareSaaSCharleston, US
Glenn Starkman(Co-Founder)inCHRISTOPHER O'ROURKE(Executive Officer)in
Co-investorsCheckmate Capital Group LLC5AM Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













